Tempus AI, Inc. (NASDAQ:TEM) is one of the stocks Jim Cramer looked at recently. When a caller asked if the stock is a buy, sell, or hold, Cramer said: Well, you know we’re not recommending stocks ...

Tem, a London-based startup, just scored $75 million in Series B funding led by Lightspeed Venture Partners, with big names like Atomico and Allianz also joining in. This puts Tem's value at over $300 ...

Tem raised $75 million to expand its AI-based energy transaction platform. The company plans launches in Texas and Australia after UK growth. Its AI engine removes costs and improves pricing for more ...

The funding round was led by Lightspeed Venture Partners and is understood to value the four-year-old company at around $300 million. Tem plans to use the capital to further develop its technology and ...

Beam-sensitive zeolites are difficult to study at high resolution because traditional electron microscopy often damages or destroys their delicate crystal structures before meaningful data can be ...

PALM DESERT, Calif. (KESQ) - The LGBTQ community is voicing strong opposition to a proposal introduced by Palm Desert Mayor Pro Tem Joe Pradetto. During a Palm Desert City Council meeting on Thursday, ...

Tempus AI, Inc. (NASDAQ:TEM) is one of the best digital health stocks to buy now. Wall Street sentiment toward Tempus AI strengthened on November 5, 2025, following the company's Q3 results, with ...

Tempus AI Inc. (NASDAQ:TEM) shares are trending on Wednesday. Check out the current price TEM of stock here. Shares of the healthcare technology company dropped 6.02% to $79.40 in after-hours trading ...

Tempus AI (NASDAQ:TEM) shares are trading higher Monday after the company announced its subsidiary, Ambry Genetics, published a peer reviewed study in Genetics in Medicine. What To Know: Tempus ...